News

CymaBay Reports First Quarter 2017 Financial Results and Provides Corporate Update

NEWARK, Calif., May 11, 2017 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced financial results and a corporate update for the quarter ended March 31, 2017.

2017-06-27T12:13:50+00:00